EP3573612A4 - Use of short chain fatty acids for the treatment and prevention of diseases and disorders - Google Patents

Use of short chain fatty acids for the treatment and prevention of diseases and disorders Download PDF

Info

Publication number
EP3573612A4
EP3573612A4 EP18744902.0A EP18744902A EP3573612A4 EP 3573612 A4 EP3573612 A4 EP 3573612A4 EP 18744902 A EP18744902 A EP 18744902A EP 3573612 A4 EP3573612 A4 EP 3573612A4
Authority
EP
European Patent Office
Prior art keywords
disorders
diseases
prevention
treatment
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18744902.0A
Other languages
German (de)
French (fr)
Other versions
EP3573612A1 (en
Inventor
Ira C. SPECTOR
Mark A. Feitelson
Alla ARZUMANYAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple University of Commonwealth System of Higher Education
Original Assignee
Temple University of Commonwealth System of Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple University of Commonwealth System of Higher Education filed Critical Temple University of Commonwealth System of Higher Education
Priority claimed from PCT/US2018/015383 external-priority patent/WO2018140687A1/en
Publication of EP3573612A1 publication Critical patent/EP3573612A1/en
Publication of EP3573612A4 publication Critical patent/EP3573612A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP18744902.0A 2017-01-27 2018-01-26 Use of short chain fatty acids for the treatment and prevention of diseases and disorders Pending EP3573612A4 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762451192P 2017-01-27 2017-01-27
US201762510867P 2017-05-25 2017-05-25
US201762530371P 2017-07-10 2017-07-10
US201762539572P 2017-08-01 2017-08-01
US201762588961P 2017-11-21 2017-11-21
PCT/US2018/015383 WO2018140687A1 (en) 2017-01-27 2018-01-26 Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Publications (2)

Publication Number Publication Date
EP3573612A1 EP3573612A1 (en) 2019-12-04
EP3573612A4 true EP3573612A4 (en) 2020-11-18

Family

ID=68342291

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18744902.0A Pending EP3573612A4 (en) 2017-01-27 2018-01-26 Use of short chain fatty acids for the treatment and prevention of diseases and disorders

Country Status (1)

Country Link
EP (1) EP3573612A4 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735967A (en) * 1985-05-28 1988-04-05 Neesby Torben E Method for desensitizing the gastrointestinal tract from food allergies
US20080107646A1 (en) * 2002-04-26 2008-05-08 Yih-Lin Chung Method for ameliorating pruritus
WO2011137173A1 (en) * 2010-04-28 2011-11-03 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
WO2012013495A1 (en) * 2010-07-29 2012-02-02 Cosmo Technologies Ltd. Pharmaceutical and/or dietary compositions based on short chain fatty acids
WO2012131069A1 (en) * 2011-03-31 2012-10-04 Proponent Biotech Gmbh Short chain fatty acids and their derivatives for use in treatment immunogenic disorders

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735967A (en) * 1985-05-28 1988-04-05 Neesby Torben E Method for desensitizing the gastrointestinal tract from food allergies
US20080107646A1 (en) * 2002-04-26 2008-05-08 Yih-Lin Chung Method for ameliorating pruritus
WO2011137173A1 (en) * 2010-04-28 2011-11-03 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
WO2012013495A1 (en) * 2010-07-29 2012-02-02 Cosmo Technologies Ltd. Pharmaceutical and/or dietary compositions based on short chain fatty acids
WO2012131069A1 (en) * 2011-03-31 2012-10-04 Proponent Biotech Gmbh Short chain fatty acids and their derivatives for use in treatment immunogenic disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EEF BOETS ET AL: "Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study : Short-chain fatty acid systemic availability and metabolism in humans", THE JOURNAL OF PHYSIOLOGY, vol. 595, no. 2, 18 September 2016 (2016-09-18), GB, pages 541 - 555, XP055694009, ISSN: 0022-3751, DOI: 10.1113/JP272613 *
See also references of WO2018140687A1 *

Also Published As

Publication number Publication date
EP3573612A1 (en) 2019-12-04

Similar Documents

Publication Publication Date Title
IL298690B1 (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
EP3621973A4 (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3454858A4 (en) Combination treatment of ocular inflammatory disorders and diseases
PT3377637T (en) Compositions and methods for the treatment of wounds, disorders, and diseases of the skin
EP3405215A4 (en) Methods for the treatment of danon disease and other disorders of autophagy
EP3596063A4 (en) Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating ire1-related diseases and disorders
EP3355879A4 (en) Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids
EP3583113A4 (en) Use of tgf alpha for the treatment of diseases and disorders
EP3639833A4 (en) Agent for the prevention or treatment of fat-related diseases and/or inflammation
ZA202006234B (en) Compositions and methods for the treatment of neurological diseases
EP3675871A4 (en) Compositions and methods for the treatment of fibrotic diseases
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
EP3481958A4 (en) Methods and compositions for treatment of disorders and diseases involving rdh12
EP3644966A4 (en) Treatment and diagnosis of ocular surface disorders
IL269400A (en) Drugs and compositions for the treatment of ocular disorders
EP3740592A4 (en) Methods and compositions for the treatment of vascular disease
EP3661502A4 (en) Compounds for the prevention and treatment of medical disorders and uses thereof
EP3538083A4 (en) Formulations for the treatment of ocular surface diseases and related methods
EP4010075A4 (en) Methods for the treatment of apoc3-related diseases and disorders
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders
EP3568138A4 (en) Compositions and methods for the treatment of myelin related and inflammation related diseases or disorders
PL3515409T3 (en) Complex and compositions for the treatment of ophthalmic and dermatological diseases
EP3573612A4 (en) Use of short chain fatty acids for the treatment and prevention of diseases and disorders
EP3585411A4 (en) Il-22bp compositions and method for the treatment of disease therewith
GB2603379B (en) Avocatin B for the treatment of diseases and conditions

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190812

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20201021

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/00 20060101ALI20201015BHEP

Ipc: A61K 31/19 20060101AFI20201015BHEP

Ipc: A61P 17/06 20060101ALI20201015BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230327